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ABSTRACT
Clonal expansion of mitochondrial DNA (mtDNA)
deletions is an important pathological mechanism
in adults with mtDNA maintenance disorders, lead-
ing to a mosaic mitochondrial respiratory chain defi-
ciency in skeletal muscle. This study had two aims:
(i) to determine if different Mendelian mtDNA mainte-
nance disorders showed similar pattern of mtDNA
deletions and respiratory chain deficiency and (ii)
to investigate the correlation between the mitochon-
drial genetic defect and corresponding respiratory
chain deficiency. We performed a quantitative anal-
ysis of respiratory chain deficiency, at a single cell
level, in a cohort of patients with mutations in mtDNA
maintenance genes. Using the same tissue section,
we performed laser microdissection and single cell
genetic analysis to investigate the relationship be-
tween mtDNA deletion characteristics and the res-
piratory chain deficiency. The pattern of respiratory
chain deficiency is similar with different genetic de-
fects. We demonstrate a clear correlation between
the level of mtDNA deletion and extent of respiratory
chain deficiency within a single cell. Long-range and
single molecule PCR shows the presence of multi-
ple mtDNA deletions in approximately one-third of all
muscle fibres. We did not detect evidence of a replica-
tive advantage for smaller mtDNA molecules in the
majority of fibres, but further analysis is needed to
provide conclusive evidence.
INTRODUCTION
Multiple mitochondrial DNA (mtDNA) deletions are
found in mitochondrial disease patients with recessive or
dominant pathogenic variants in proteins required for
mtDNA replication and maintenance (1–4). In patients
with mtDNA maintenance disorders, the multiple mtDNA
deletions accumulate later in life; however, some gene vari-
ants are also associated with symptoms in infancy and
childhood due to mtDNA depletion (5). The later onset of
symptoms due to mtDNA deletions is likely due to the mul-
tiple copies of mtDNA within cells, and therefore the time
taken for mtDNA deletions to reach a proportion at which
a critical biochemical threshold, necessary to cause a bioen-
ergetic deficit, is exceeded.
Clonally expanded mtDNA deletions are known to be
an underlying cause of mitochondrial oxidative phospho-
rylation (OXPHOS) deficiency in post-mitotic cells, with
studies demonstrating higher levels ofmtDNAdeletion het-
eroplasmy in cytochrome c oxidase (COX; complex IV)-
deficient cells (6–9). These clonally expanded mtDNA dele-
tions form and then accumulate at different times in adja-
cent cells leading to heterogeneity and mosaicism of adja-
cent muscle fibres (10). Recent work has demonstrated that
the threshold level of a single mtDNA deletion required to
cause OXPHOS deficiency is different for complex I and
complex IV (11). Furthermore, different thresholds are ob-
served depending on the size and location of the resulting
mtDNA deletion that together determine the number of
complex I (CI), CIV and tRNA genes deleted (11).
Whilst these relationships appear straightforward in pa-
tients with single, large-scale mtDNA deletions, they are
likely to be more complex in patients with multiple mtDNA
deletions. A systematic analysis to assess the relationship
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betweenmtDNA genetics and OXPHOS deficiency at a sin-
gle cell level has not been completed for patients with multi-
ple mtDNA deletions. Furthermore, a range of pathogenic
variants in numerous Mendelian-inherited mtDNA main-
tenance genes can lead to the accumulation of multiple
mtDNA deletions and there is no comparison of genotype
differences in mtDNA deletion spectra, and OXPHOS de-
ficiency profile, of these patients.
Here we use a quantitative quadruple immunofluores-
cent technique (12) to assess whether there are differences
in the biochemical phenotype between different autoso-
mal recessive and autosomal dominant nuclear gene vari-
ants resulting in multiple mtDNA deletions. Quadruple im-
munofluorescence in combination with fibre typing and
single-cell mtDNA analysis are subsequently used to corre-
late mtDNA deletion level and mtDNA copy number with
respiratory chain phenotype and muscle fibre type to better
understand the mitochondrial genetics underpinning these
diseases. Finally, we use single-molecule PCR combined
with real-time PCR to measure the proportions of mtDNA
molecules of up to three different lengths within single cells.
PATIENTS AND METHODS
Patients
Muscle biopsies of 16 patients with genetically and clinically
characterized mitochondrial disease of nuclear origin were
included in the study, six of them were further investigated
using single-cell studies. Patients had a range of mtDNA
maintenance disorders with diagnostically confirmed, seg-
regating pathogenic variants in POLG, TWNK, SLC25A4
and RRM2B.
Clinical data and genotypes are summarized in Table
1. Genetic and data analysis were performed in compli-
ance with protocols approved by the Ethical Committee of
theMartin LutherUniversityHalle-Wittenberg.Written in-
formed consent was obtained from all participants prior
to study inclusion. Three of the cases (patients 7, 8 and
16) were investigated with informed consent by the New-
castle and North Tyneside Local Research Ethics Commit-
tees (reference 2002/205). Control tissue was acquired with
prior informed consent from people undergoing anterior
cruciate ligament surgery, following approval by Newcas-
tle and North Tyneside Local Research Ethics Committees
(reference 12/NE/0395).
OXPHOS quadruple immunofluorescence
Quadruple immunofluorescence was carried out on trans-
verse muscle cryosections (10 m) as described previously
(12). An antibody against CI subunit NDUFB8 was used
to detect CI deficiency. CIV was detected by an antibody
against mtDNA encoded COX subunit I (COX-I). Porin, as
an outer mitochondrial membrane voltage-gated ion chan-
nel, was used to quantify mitochondrial mass and laminin,
as a basement membrane glycoprotein, was used to label
myofibre boundaries. Analysis was performed as reported
previously (12).
Fibre typing
Fibre typing was carried out on transverse muscle cryosec-
tions (20 m) from six patients. Serial sections of 10 m
were used for quadruple immunofluorescence, so the fibres
could be matched after staining for OXPHOS targets. The
protocol was performed as previously (13), but with some
modifications according to Rocha et al. (11).
Matching of fibres and grouping according to their respira-
tory chain deficiency
After quadruple immunofluorescence staining, fibres were
grouped depending on their respiratory chain deficiency
into three different groups (Figure 1). The first group were
completely normal for levels of CI and CIV (CI+ and
CIV+), the second CI-deficient (CI- and CIV+) and the
third CI- and CIV-deficient (CI- and CIV-).
Each cell of the fibre-typed section was then matched
with the corresponding fibre from the quadruple im-
munofluorescence staining. In each of the three MRC
groups, fibres were grouped according to their ODporin
value and according to their fibre type (type 1, type 2a, type
2x). Finally, fibres were selected randomly out of all groups
for molecular analysis (Figure 1).
Image acquisition
Brightfield and fluorescent images were acquired at 20×
magnification using a Zeiss Axio Imager Z2 with a motor-
ized stage and AxioVision (Release.4.8.2) and Zen 2 pro
software, with monochrome (AxioCam MRm) and colour
(AxioCamMRc)Digital Cameras and filter cubes for Alexa
Fluor dyes at 750 nm (laminin), 488 nm (COX-I), 546 nm
(porin) and 647 nm (NDUFB8) wavelengths, respectively.
Exposure time setup, image record and image processing
have been performed as described previously (12).
Densitometry measurements and data analysis
Fluorescent images were analysed using an in-house devel-
oped Matlab-based software (available upon request). Ex-
ported data were uploaded to a website to perform back-
ground correction and statistical analysis (http://research.
ncl.ac.uk/mitoresearch/). Fibre-surfaces were created auto-
matically over all channels; however, unwanted areas like
vessels, folds or background were removed manually. At the
end of fibre analysis, the software created a merged data-
file, including all individual values of patients and controls,
which has been exported as a .csv for further statistical anal-
ysis according to Rocha et al. (12). Using the merged data,
MRC-plots for each patient and control have been created.
The plots included z-scores for COX-I, NDUFB8 and Porin
values for each myofibre analysed.
Real-time PCR analysis from single cells
A triplex real-time PCR assay was used to quantifymtDNA
deletion level as described previously (14). This method
quantifies relative levels of MT-ND4, MT-ND1 and D-
Loop, using TaqMan chemistry. Primers and TaqMan
MGB probes used have been previously reported (14,15).
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Table 1. Clinical information from patients included in this study
Subjects Gender
Age of
onset
Age at
biopsy Phenotype
Skeletal muscle
histochemistry
Multiple mtDNA
deletions Genotype
Patients with autosomal dominant mutations
P 1 f 36 46 CPEO 30–40% COX-ve;
3–5% RRF
Southern blot,
LRPCR
p.(Phe961Ser) POLG
P 2 f n.k. 39 CPEO 9% COX-ve;
increased number of
RRF
LRPCR, qPCR p.(Tyr955Cys) POLG
P 3 m Since
youth
52 CPEO, hypoacusis,
neuropathy, muscle
weakness, exercise
intolerance
10% COX-ve; 2%
RRF
Southern blot,
LRPCR
p.(Lys319Glu)
TWNK
P 4 f 57 60 CPEO, deafness 8–10% COX-ve; 1%
RRF
LRPCR p.(Met455Thr)
TWNK
P 5 f 48 58 CPEO slightly increased
number of COX-ve;
1% RRF
LRPCR p.(Arg354Pro)
TWNK
P 6 a,b m n.k. 47 CPEO, bilateral
ptosis
20% COX-ve; 8%
RRF
LRPCR p.(Asp104Gly)
SLC25A4
P7c f n.a 31 CPEO 10% COX-ve, 1%
RRF
LRPCR p.(Arg374Gln)
TWNK
Patients with autosomal recessive mutations
P 8 d m n.k. 36 Severe CPEO, ptosis,
proximal muscle
weakness, facial
weakness, scapulae
winging, low BMI,
hypogonadism and
osteoporosis
45% COX-ve; 15%
RRF
LRPCR p.(Thr144Ile) and
p.(Gly273Ser)
RRM2B
P 9 a,c, e f n.k. 43 Severe CPEO,
asymmetrical ptosis,
proximal and distal
muscle weakness,
ataxia, SNHL, facial
weakness, low BMI,
leukoencephalopathy
and depression
22% COX-ve; 8%
RRF
LRPCR p.(Arg186Gly) and
p.(Thr218Ile)
RRM2B
P 10 m Since
youth
54 CPEO, dementia,
neuropathy
20% COX-ve; 10%
RRF
Southern blot,
LRPCR
p.(Gly848Sser) and
p.(Ala899Thr) POLG
P 11 m 23 25 Stroke-like episode,
ataxia, proximal
muscle weakness,
dysphagia
5–7% COX-ve; no
RRF
LRPCR p.(Gly848Ser) and
p.(Arg627Gln) POLG
P 12 m n.k. 43 CPEO, muscle
weakness
22% COX-ve; 1%
RRF;
Southern blot,
LGPCR
homozygous
p.(Trp748Ser) POLG
P 13f f 23 37 CPEO, neuropathy,
dysarthria, seizures
<1% COX-ve; <1%
RRF
LRPCR p.(Arg467Thr) and
p.(Trp748Ser) POLG
P 14 f 67 77 CPEO, neuropathy 10% COX-ve; 1%
RRF
LRPCR p.(Arg467Thr) and
p.(Thr919Leu) POLG
P 15 f 26 36 CPEO 17%, COX-ve, 9%
RRF
Southern blot,
LRPCR
homozygous
p.(Gly426Ser) POLG
P 16 m 25 80 CPEO 20% COX-ve, 4%
RRF
LRPCR p.(Thr251Ile) and
p.(Arg467Thr) POLG
Key: y = years old; CPEO = chronic progressive external ophthalmoplegia; SNHL = Sensorineural hearing loss; BMI = body mass index; RRF = ragged
red fibres; COX-ve = COX-deficient fibres; LRPCR = long range PCR; n.k = not known. a-f indicate previously published cases. a: Rocha et al. (2015),
b: Deschauer et al. (2015), c: Vincent et al. (2018), d: Gorman et al. (2015), e: Pitceathly et al. (2012), f: Hanisch et al. (2015).
PCRamplificationwas completed in a 15l reaction in trip-
licate for each sample, with each plate containing a serial
dilution of p7D1 plasmid for standard curve generation,
as reported previously (14). Due to double/triple-stranded
nature of the D-Loop region, we considered samples to be
normal when theMT-ND1/D-Loop orMT-ND4/D-Loop
percentage deletion was between 0 (all mtDNA copies con-
tain double-stranded D-Loop) and 33% (all mtDNA copies
contain triple-stranded D-Loop), as described previously
(14). Therefore, values of >33% indicated the presence of
an mtDNA deletion species.
Long-range PCR
Long-range PCRwas carried out using LA TaqDNA poly-
merase (TaKaRa) on individual myofibres. For ∼16 Kb
amplification of individual myofibres primer pair 3F (m.3-
27) and 16360R (m.16360-16384) were used, and for 12
Kb amplification primer pairs 2549F (m.2549-2569) and
14375R (m.14375-14356) or 323F (m.323-343) and 11605R
(m.11605-11586) were used (NC 012920.1). For all long-
range PCR reactions, LATaq reaction (50l) was prepared
as follows: 5 l buffer, 0.4 M each of dNTPs, 0.4 M
forward and reverse primers, 2.5 units of polymerase, 2 l
DNA and nuclease-free water up to 50 l. Cycling condi-
tions were: 94◦C for 1 min; 35 cycles of 94◦C for 30 s, 58◦C
for 30 s and 68◦C for 16 min; 72◦C for 19 min.
mtDNA deletion breakpoint sequencing
Long-range PCR products were cleaned up using Agen-
court AMPure XP beads and quantity and quality as-
sessedwith aNanoDrop (ND-1000, Labtech international).
About 100 ng of each DNA sample was then fragmented,
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Figure 1. Quadruple immunofluorescence and selection of fibres for the molecular analysis of six patients. (A) Three serial muscle sections were taken
from each patient biopsy for OXPHOS and fibre type analysis. The OXPHOS section was sequentially overlaid with all primary and secondary antibodies,
whereas the no primary control section was only overlaid with the laminin antibody and all secondary antibodies. The fibre type section was overlaid
with antibodies, detecting type I and type II myosin heavy chain. (B) Example quadruple immunofluorescent images for patient 3 with a TWNK variant.
NDUFB8 is used as a complex I (CI) marker, MTCOI (COXI) as a complex IV (CIV) and VDAC1 as a mitochondrial mass marker. The merged image
also includes the membrane marker laminin; scale bar: 50 m. (C) Each cell of the fibre typed section was then matched with the corresponding fibre from
the quadruple immunofluorescence staining. Depending of the ODporin values and the different fibre types (type 1, type 2a, type 2x), fibres were selected
randomly out of each group for molecular work.
barcoded, size-selected and amplified using IonXpress Plus
Fragment Library Kit, Ion Xpress Barcode Adapters and
E-Gel Size Select 2% agarose gels (Thermo Fisher Scien-
tific), according to the manufacturer’s recommendations.
Individual libraries were quantified using an Agilent Bioan-
alyzer DNA High Sensitivity kit and pooled in equimolar
concentrations.
Template preparation and Ion 316 chip v2 loading were
performed on the Ion Chef (Thermo Fisher Scientific) and
chips were sequenced on the Ion PGM (Thermo Fisher
Scientific) using the Ion PGM Hi-Q View Chef kit as per
the manufacturer’s instructions (Thermo Fisher Scientific).
Data alignments to the revised Cambridge mtDNA refer-
ence sequence (NC 012920.1) were completed with the Tor-
rent Suite software v5.4.0. Aligned data were visualized and
mtDNA deletion breakpoints identified using IGV v2.3.75
(Broad Institute) (16). Sequencing data were deposited in
the NCBI sequence read archive (Accession number: PR-
JNA527002).
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Figure 2. Mitochondrial respiratory chain (MRC) expression profile for complex I, complex IV and porin levels. Plots show complex I and IV expression
profile from patients with (A) autosomal dominant mutations, n = 6 and (B) autosomal-recessive mutations, n = 8. Each dot represents the measurement
from an individual muscle fibre, colour coded according to its mitochondrial mass (very low: blue, low: light blue, normal: light orange, high: orange and
very high: red). Thin black dashed lines indicate the SD limits for the classification of fibres, lines next to x and y axis indicate the levels of NDUFB8
and COX-I, respectively (beige: normal, light beige: intermediate(+), light blue: intermediate(−) and blue: deficient). Bold dashed lines indicate the mean
expression level of normal fibres. Immunofluorescent data used to generate these plots is provided in Supplementary Data file 1.
Assessment of mtDNA deletion proportions in single cells
Serial cryosections from three patients were treated for
COX/SDH histochemistry (first and third section) and
SDH histochemistry (second section). The SDH slide was
used for laser micro-dissection of COX-deficient fibres (as
assessed by COX/SDH histochemistry on adjacent sec-
tions). Single cells were laser micro-dissected (Zeiss PALM
laser capture microscope) and lysed using a QIAmp DNA
micro (Qiagen), following the manufacturer’s instructions.
Single cell lysates were assessed using single molecule PCR
and ND1/ND4 real-time assay (15).
Single-molecule PCR (smPCR) is an artefact-free ap-
proach to analysemtDNAdeletions, since amplification oc-
curs from a single mtDNA molecule (17,18). For smPCR,
the extracted DNA from above was diluted to a template
concentration that yielded an amplicon from less than a
quarter of PCR reactions. smPCR was carried out as two
reactions, as described previously (19). For the first round,
primers were 2999F (m.2999-3028) and 2949R (m.2949-
2918), and PCR products from the first round were used
with 3160F (m.3160-3191) and 2949R (m.2462-2494) for
the second round. Based on the proportion of wells con-
taining an amplicon, it was possible to calculate the dilu-
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tion of template DNA needed to achieve single molecule
PCR based on a Poisson probability table. The above two-
round PCR was repeated with the desired template concen-
tration, yielding no more than a 1 in 4 success rate across a
96-well plate. The proportion of wells containing an ampli-
con was used to determine the relative proportion of differ-
ent mtDNA deletion species.
RESULTS
Serial sections from skeletal muscle biopsies of patients
with mtDNA maintenance disorders were subjected to im-
munofluorescent analyses to assess respiratory chain pro-
tein levels and fibre type (Figure 1). The set-up of the ex-
periment allowed subsequent single-cell genetic analysis.
Different mtDNA maintenance disorder genotypes have sim-
ilar biochemical signatures
Quantitative quadruple immunofluorescent (IF) staining
was used to evaluate biochemical signatures in patients
with mtDNA maintenance disorders (n = 14) and to assess
whether there is a difference between recessively and domi-
nantly inherited pathogenic variants. Data provided in sup-
plementary data file 1. Comparing the IF images of all pa-
tients we observedMRC-profiles similar to those previously
reported (12), with no obvious differences between domi-
nant (Figure 2A) and recessive (Figure 2B) mutations. We
defined three groups of fibres: respiratory chain normal, CI-
deficient orCI- andCIV-deficient (Figure 2). This pattern of
deficiency was particularly obvious for those patients show-
ing more than 20% COX-deficient fibres in muscle biopsy
(Table 1), e.g. P1, P6, P7, P8, P9, P11.
Ragged-red fibres (RRF) are a common finding in pa-
tients with adult-onset mtDNAmaintenance disorders and
demonstrate hyperproliferation of mitochondria in a subset
of muscle fibres. We used high porin levels as a marker for
RRFfibres and compared cells from images ofmuscle fibres
previously classified as normal and RRF by visual inspec-
tion. Based on the porin z-scores for a subset of classified
fibres, we defined RRF fibres as those with a porin z-score
> 2.5. We find that the majority (535 out of 636 or 84.1%)
of RRF are deficient for both CI and CIV, 10.5% (67 out of
636) have isolated CIV deficiency and only 0.3% (2 out of
636) have isolated CI deficiency. The majority (30 out of 38
or 78.9%) of RRF are classified as type I muscle fibres, with
18.4% (7 out of 38) being type IIa and 2.6% (1 out of 38)
type IIb.
Respiratory chain deficiency is associated with a higher level
of mtDNA deletion at a single-cell level
To correlate the underlying mtDNA deletions with the bio-
chemical deficiency at a single-cell level, six patients (P3, P6,
P7, P8, P11 and P14) from the 14 that underwent quadru-
ple immunofluorescence were selected for genetic analysis
by triplex real-time PCR (Figure 3). Raw Cq, mtDNA copy
number and deletion level for each cell is provided in sup-
plementary data file 2. In all six patients, we observed that
mtDNA deletion level is higher in fibres with CI or CI and
CIV deficiency than those which are respiratory chain nor-
mal (Figure 3). In order to retain multiplexed data from the
triplex real-time assay and assess this in the context of res-
piratory chain deficiency, 2D scatter plots of MT-ND1/D-
Loop versus MT-ND4/D-Loop were coloured based on
MT-ND4/MT-ND1 (Figure 3). mtDNA deletions leading
to a loss of MT-ND4 were most prevalent (85.6% of all
deleted species, 166 out of 194) in all six patients (light blue
box, Figure 3), with deletions encompassing MT-ND1 but
not MT-ND4 (light orange box, Figure 3) less common
(3.1%, 6 out of 194) and observed in four of six patients
(P3, P7, P8 and P11). Finally, four out of six patients also
had deletions encompassing both MT-ND1 and MT-ND4
(11.3%, 22 out of 194) (light purple box, Figure 3, P3, P6,
P8 and P11).
Respiratory chain deficiency is not associated with mtDNA
depletion in these patients
Respiratory chain deficiency can also be caused by a de-
pletion of mitochondrial mass and mtDNA. Therefore, we
sought to investigate whether respiratory chain deficiency
was associated with a quantitative loss of mtDNA copy
number and mitochondrial mass (Figure 4). Comparing
all three groups of fibres, no obvious sign of mtDNA de-
pletion was observed in respiratory-deficient muscle fibres
compared to normal muscle fibres. In contrast, a signifi-
cantly higher level of total D-Loop mtDNA copy number
was detected in fibres withCI deficiency orwith bothCI and
CIV deficiency, compared to normal fibres (P < 0.0001, A;
n = 114, B; n = 64, C; n = 118). However, no significant
difference was detected between CI-deficient and CI- and
CIV-deficient fibres (Figure 4A).
Since a reduction in wild-type copy number is associated
with respiratory chain deficiency, we examined the relation-
ship betweenMT-ND4 as ameasure of wild-type copy num-
ber and respiratory chain deficiency (Figure 4B).MT-ND4
wild-type mtDNA copy number showed no significant dif-
ference between normal fibres (n = 114) and CI-deficient
fibres (n= 64). Wild-type mtDNA copy number was signif-
icantly lower in CI- and CIV-deficient fibres (P < 0.0001, n
= 118, Figure 4B).
Since a change in total copy number may also be asso-
ciated with a change in mitochondrial mass, we looked to
see whether there were significant differences between porin
levels in Type I (Figure 4C) and type II (Figure 4D) fibres.
We find that mitochondrial mass is significantly higher in
CI- and CIV-deficient fibres than normal or CI-deficient fi-
bres in type I fibres. In type II fibres, mitochondrial mass is
significantly higher in both CI- deficient and CI- and CIV-
deficient fibres than CI normal fibres.
We see up to three mtDNA deletion species in a single muscle
fibre
Since real-time PCR does not indicate how many mtDNA
deletions or what size mtDNA deletions are contained
within each cell, we selected a subset of cells and amplified
mtDNA by long range PCR to detect mtDNA deletions.
DNA from 21 single muscle fibres from patients 3, 6, 7 and
14 was amplified, and the mtDNA breakpoints sequenced
(Figure 5). In Figure 5, mtDNA sequences are labelled with
a cell number (1-21) and a letter (X,Y,Z) denoting unique
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Figure 3. Triplex real-time PCR results of six patients. Deletions as proportions of two mtDNA targets:MT-ND4/MT-ND1 is the proportion ofMT-ND4
per MT-ND1. MT-ND1/D-Loop is the proportion of MT-ND1 relative to the D-Loop. MT-ND4/D-Loop is the proportion of MT-ND4 relative to the
D-Loop. Every point represents a single muscle fibre, analysed by real-time PCR. The squares show muscle fibres classed as normal for both complex I
and complex IV, circles represent fibres deficient for complex I and normal for complex IV and triangles deficient for both complex I and IV. The dashed
line marks where MT-ND4/D-loop and MT-ND1/D-loop percentage deletion equals 33%. Fibres ≤ 33% of MT-ND1/D-Loop or MT-ND4/D-Loop
percentage deletion were considered to be without any deletion due to the double/triple-stranded nature of the D-Loop region. Colouring indicates the
MT-ND4/MT-ND1 proportion. Areas corresponding to deletions ofMT-ND4 are shaded in light blue, deletions ofMT-ND1 in light red and bothMT-
ND1 andMT-ND4 in light purple. Data used to generate these plots is provided in supplementary data file 2.
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Figure 4. Exploring relationship between mtDNA copy number and mitochondrial mass with respiratory chain deficiency in patients 3, 7–10 and 16. For
all plots box and whiskers show mean, 25th and 75th percentiles, minimum and maximum. (A) D-Loop (total) mtDNA copy number fibres were grouped
as CI+ CIV+, CI- CIV+ and CI- CIV-. A significantly higher level of copy number is detected in both CI- CIV+ and CI- CIV- compared to CI+ CIV+
(P < 0.0001, Mann–Whitney). No significant difference is noted between CI- CIV+ and CI- CIV- (Mann–Whitney). (B) ND4 (wild-type) mtDNA copy
number for CI+ CIV+, CI- CIV+ and CI CIV- fibres. No significant difference in copy mtDNA copy number between CI+ CIV+ and group CI- CIV+
(Mann–Whitney). In comparison, there is a significantly lower wild-type copy number in groups CI- CIV- compared to groups CI+ CIV+ and CI- CIV+
(P < 0.0001, Mann–Whitney). (C) Porin level for CI + CIV+, CI- CIV+ and CI- CIV- type I muscle fibres. (D) Porin level for CI+ CIV+, CI- CIV+, CI-
CIV- type II fibres.
mtDNA sequence (deletion species) in a single cell. Of these
21 cells, 66.7% (14 cells) harboured a single mtDNA dele-
tion, 23.8% (5 cells) had two detectable mtDNA deletions
and 10.0% (2 cells) harboured three mtDNA deletions (Ta-
ble 2) with a total of 31 mtDNA deletion species identified
overall. All mtDNA deletions removed at least part of the
major arc with half of them also removing part of the minor
arc (Figure 5). Most deletions removing bothMT-ND1 and
MT-ND4 are from P3 (n = 9), with only one from P14. For
all fibres where both breakpoint sequencing and real-time
datawere available, the twomethods provided agreement on
the removal ofMT-ND1,MT-ND4 or both. Of 31 mtDNA
deletions sequenced 13 (42%) had a repeat sequence of 2–
11 bp in length at the break-point, of these all were perfect
repeats.
Molecular genetics do not strictly correlate with respiratory
chain deficiency in fibres with multiple mtDNA deletions
Using data from quadruple immunofluorescence, real-time
PCR and mtDNA deletion breakpoint sequencing we
sought to correlate the molecular findings with the ob-
served respiratory chain deficiency. However, when multi-
ple mtDNA deletions were present in a single cell it was
often not possible to tell what proportion of each mtDNA
deletion species was present (Table 2). Furthermore, in con-
trast to the clear-cut genetic and biochemical correlations
reported by Rocha et al. (11), where a single mtDNA dele-
tion was identified by long range PCR, we observed some
muscle fibres where all three COX genes are deleted at high
levels and yet the cell demonstrates only isolated CI defi-
ciency at the immunohistochemical level (e.g. cells 2–8, 13
and 19 in Figure 5 and Table 2).
Data do not conclusively suggest a replicative advantage for
larger mtDNA deletion species
It has previously been suggested that mtDNA deletions
may clonally expand due to a replicative advantage, since
deleted species are smaller and can therefore be replicated
faster (20). Long-range PCR has an inherent bias towards
smaller mtDNA molecules and therefore does not allow us
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Table 2. Characterization of mtDNA deletions found by long-range PCR and breakpoint sequencing. If breakpoints contained a repeat, only those with
a repeat 3 bp or longer were indicated; any repeats 2 bp or shorter were classed as no repeat
PCR
Product Patient
np 5’
break-
point
np 3’
break-
point Primers used
Deletion size
based on
sequencing
[bp]
ND1/D-
Loop
[%]
ND4/D-
Loop
[%]
5′ breakpoint
sequence
3′ breakpoint
sequence
Repeats
at break-
points
1X P3 3270 11195 323F/12054R 7924 75.1 39.8 5′-GGTAATCGCA
TAAAACTTAA
AAC-3′
5′-GGCACATACT
TCCTATT-3′
no repeat
2X P3 3263 12299 2549F/14374R 9035 90.5 86.9 5′-TAATCGCATA
AAAC-3′
5′-AGGCCCCA
AAAATTTT-3′
no repeat
2Y 4351 13924 9572 5′-TATGAGAATC
GAACCC-3′
5′CCCTAGCATC
ACACACC-3′
no repeat
2Z 3326 11668 8341 5′-CATACCCATG
GCCAACs(CTCC
T)-3′
5′-(CTCCT)CCAA
ACCCCC-3′
5bp
perfect
repeat
3X P3 5791 12302 6510 19.9 93.8 5′-GGCAGGTT
TGAAGCTGCT
TCTTCG-3′
5′-GCCCCAAA
AATTTTGGT-3′
no repeat
4X P3 5786 13238 7451 7.9 69.3 5′-CAGGTTTGAA
GCTGCTT-3′
5′-TCGTAGCCTT
CTCCAC-3′
no repeat
4Y 8591 11464 2872 5′-
GGCCTACCC(GC
CGCAGTACT)-3′
5′-(GCCGCAGT
ACT)CTTAAAAC
TAGGC-3′
11bp
perfect
repeat
5X P3 3914 12299 8384 19.9 91.9 5′-CCCCCTTCGA
CCTTGCCGAA
GG-3′
5′-AGGCCCCA
AAAATTTT-3′
no repeat
6X P3 3263 11493 323F/12054R 8229 24.7 80.2 5′-TAATCGC(AT
AAAAC)-3′
5′-
(ATAAAAC)GCCT
CACACTCATT-3′
7bp
perfect
repeat
7X P3 4351 12111 2549F/14374R 7759 4.0 99.1 5′-TAGGACTATG
AGAATCGAAC
CC-3′
5′-CCCCGACATC
ATTACCGG-3′
no repeat
8X P3 5787 13924 8136 7.5 95.4 5′-CAGGTTTGAA
GCTGCTTC-3′
5′CCCTAGCATC
ACACACCG-3′
no repeat
9X P3 4376 13923 9546 18.4 99.5 5′-GAATCCAA
AATTCTCCG-3′
5′-CCCTAGCATC
ACACACCG-3′
no repeat
9Y 5786 13238 7451 5′-CAGGTTTGAA
GCTGCTT-3′
5′-TCGTAGCCTT
CTCCAC-3′
no repeat
9Z 3260 12299 9038 5′-GCCCGGTAAT
CGCATAA-3′
5′-
AGGCCCCAAA
AATTTTGGT-3′
no repeat
10X P3 5825 13923 8097 0.0 96.6 5′-AAAATCACCT
CGGAGC-3′
5′-CCCTAGCATC
ACACACC-3′
no repeat
11X P6 6226 12107 2549F/14374R 5880 14.2 94.6 5′TTCTGACTCT
TACCCC(TCCC
TC)-3′
5′-(TCCCTC)AA
CCCCGAC-3′
6bp
perfect
repeat
11Y 8482 13460 4977 5′-CCACCT(ACCT
CCCTCACCA)-3′
5′-(ACCTCCCTCA
CCA)TTGGCAGC
CTAGCA-3′
13bp
perfect
repeat
12X P6 7809 14001 6191 8.8 92.3 5′TCCTGCCCGC
CATCA(TCCTAG
ACCT)-3′
5′-(TCCTAGAC
CT)AACCTGAC
TAGAAAA-3′
10bp
perfect
repeat
12Y 6226 12107 5880 5′-
TTCTGACTCTTA
CCCC(TCCCTC)-
3′
5′-(TCCCTC)AA
CCCCGAC-3′
6bp
perfect
repeat
13X P11 6341 14005 7663 95.6 33.7 5′-GCCTCCG(TA
GACCTAACC)-3′
5′-(TAGACCTAAC
C)TGACTAGAAA
AGCTA-3′
11bp
perfect
repeat
13Y 5787 13923 2549F/14374R 8135 5′-CAGGTTTGAA
GCTGCTTC-3′
5′-CCCTAGCATC
ACACACCG-3′
no repeat
14X P11 6880 13457 6576 18.6 97.4 5′-TTTAGCTGAC
TCGCCAC-3′
5′-CCATTGGCAG
CCTAGCATT-3′
no repeat
15X P11 5787 13924 8136 14.9 67.2 5′-CAGGTTTGAA
GCTGCTTC-3′
5′-CCTAGCATCA
CACACCG-3′
no repeat
16X P11 6341 14005 7663 13.6 94.2 5′-GCCTCCG(TA
GACCTAACC)-3′
5′-(TAGACCTAAC
C)TGACTAGAAA
AGCTA-3′
11bp
perfect
repeat
17X P11 5788 13922 8133 10.3 94.6 5′-CAGGTTTGAA
GCTGC(TTCT)-3′
5′-(TTCT)ACCC
TAGCATCACA
CACC-3′
4bp
perfect
repeat
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Table 2. Continued
PCR
Product Patient
np 5’
break-
point
np 3’
break-
point Primers used
Deletion size
based on
sequencing
[bp]
ND1/D-
Loop
[%]
ND4/D-
Loop
[%]
5′ breakpoint
sequence
3′ breakpoint
sequence
Repeats
at break-
points
18X P14 3270 11195 2549F/14374R 7924 0.0 82.8 5′-GGTAATCGCA
TAAAACTTAA
AAC-3′
5′-GGCACATACT
TCCTATT-3′
no repeat
19X P14 5788 13923 8134 0.0 85.3 5′-
GGCAGGTTTG
AAGCTGCTTCT-
3′
5′-CCCTAGCATC
ACACACC-3′
no repeat
19Y 4351 12111 7759 5′-TAGGACTATG
AGAATCGAAC
CC-3′
5′-CCCCGACATC
ATTACCGG-3′
no repeat
20X P14 5787 13923 8135 13.0 45.1 5′-CAGGTTTGAA
GCTGCTTC-3′
5′-CCCTAGCATC
ACACACCG-3′
no repeat
21X P14 6798 14269 7470 4.1 95.7 5′-TTTACAGTAG
GAATAGACG-3′
5′-CGAATCAACC
CTGACCCCTCT-
3′
no repeat
to accurately assess the relative proportions of eachmtDNA
deletion. In comparison smPCR requires the dilution of
template DNA down to the point that any reaction where
the amplicon produced must contain only a single mtDNA
molecule therefore removing this bias and allowing quan-
titative assessment (17). To investigate the possibility of a
replicative advantage for smaller species, we performed sin-
gle molecule PCR (smPCR). Single muscle fibres were laser
micro-dissected from patients P7, P8 and P16 with POLG
(n = 1), TWNK (n = 1) and RRM2B (n = 1) mutations re-
spectively, and smPCR performed. The data from this are
summarized in Table 3.
We find that 62.8% of affected cells contained a single
mtDNA deletion, 34.6% contained two mtDNA deletion
species and 2.6% three mtDNA deletion species. These val-
ues are similar to thosewe report above fromour long-range
PCRanalysis and also to those previously reported in Inclu-
sion Body Myositis (IBM) (19). We also note that there is
no difference in the size of mtDNA deletions between the
three different genotypes.
In the cells containing multiple mtDNA deletion species,
we were able to examine whether the smaller of the species is
most prevalent. We find that in P7 the largest mtDNA dele-
tion (the smallest species of mtDNA molecule) was most
prevalent in 4/10 cells (40.0%) with multiple deletions. In
P8, the smallest species was most prevalent in 5/12 cells
(41.7%), and in P16 the smallest mtDNA species was the
most prevalent in 3/8 cells (37.5%).
DISCUSSION
Here, we perform a single-cell investigation of the genetic
and biochemical correlations and underlying pathomech-
anisms of patients with adult-onset mtDNA maintenance
disorders. Rocha et al. (2018) have previously shown a
strong correlation between mitochondrial genetics and res-
piratory chain deficiency in patients with single, large-scale
mtDNA deletions. Therefore, the first aim of this study was
to investigate whether a similar correlation was observed
in patients with nuclear variants causing multiple mtDNA
deletions. A replicative advantage of deleted––and therefore
smaller––mtDNAmolecules is one possible explanation for
the clonal expansion of mtDNA mutations. Consequently,
a second aim of this study was to ask whether a replicative
advantage for smaller mtDNA molecules exists.
Quadruple immunofluorescent staining confirmed the
distinct MRC-pattern previously reported in a small num-
ber of patients (12) with fibres divided into three groups:
respiratory chain normal fibres, isolated CI deficiency, and
cells with combined CI and CIV deficiency. We observed
no obvious differences between patterns associated with re-
cessively inherited or dominantly inherited variants, or be-
tween the different nuclear encoded mtDNA maintenance
genes. This is most likely due to the stochastic nature of
mtDNAdeletion formation and clonal expansion in patient
muscle.
We then probed deeper at a single-cell level to assess
mtDNA deletion level and determine if this correlated with
CI- and CIV-respiratory chain deficiency. Muscle biopsies
from six patients were selected for further investigation
by triplex real-time PCR in single muscle fibres. Our data
showed that a higher mtDNA deletion level is associated
with an increase in CI and CIV deficiency and an increase
in mitochondrial mass. However, compared to results by
Rocha et al. (11), the correlation betweenmitochondrial ge-
netics and respiratory chain deficiency in mtDNA mainte-
nance disorders ismuchmore complicated. This is likely due
to the complex nature of multiple mtDNA deletions, where
patient muscle fibres sometimes contained more than one
single mtDNA deletion species, which may lead to the loss
of different mtDNA-encoded genes. This means that in or-
der to build a complete picture it is also necessary to assess
how many mtDNA deletions are present and where in the
mtDNA these deletions are located (11).
In order to determine the number, location and propor-
tion of mtDNA deletions present in each muscle fibre we
selected a subset of fibres for long-range PCR and mtDNA
sequencing. We had hoped that this would demonstrate
a similar pattern in biochemical threshold as reported by
Rocha et al. (11); however, this was not simple to deter-
mine. Of the sequenced mtDNA deletions, 10 out of 31
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Table 3. Summary of results from single molecule PCR
Deletion 1 Deletion 2 Deletion 3
Fibre
No. of
deletions
ND4/ND1
% deletion
load Size (Kb) Proportion Size (Kb) Proportion Size (Kb) Proportion
Is the largest
deletion
highest level?
Patient 7 TWNK
1 2 72 4 0.23 5 0.77 Yes
2 1 32 5 1
3 2 73 6 0.69 7 0.31 No
4 2 85 5 0.86 7 0.14 No
5 1 69 7 1
6 1 29 5 1
7 2 84 4 0.28 5 0.72 Yes
8 2 98 5 0.25 7 0.75 Yes
9 1 83 7 1
10 1 u.m 5 1
11 1 28 5 1
12 1 83 7 1
13 2 82 6 0.42 7 0.58 Yes
14 1 90 5 1
15 1 30 6 1
16 1 43 7 1
17 1 81 8 1
18 1 u.m 6 1
19 2 47 5 0.67 10 0.33 No
20 1 86 6 1
21 1 81 5 1
22 1 95 5 1
23 2 95 6 0.8 9 0.2 No
24 1 89 5 1
25 2 61 6 0.79 10 0.21 No
26 2 77 6 0.86 10 0.14 No
Patient 8 RRM2B
1 2 17 4 0.6 5 0.4 No
2 2 67 8 0.2 9 0.8 Yes
3 1 <5 5 1
4 1 <5 4 1
5 1 37 5 1
6 1 59 3 1
7 3 97 6 0.49 6 0.4753 10 0.39 No
8 1 62 6 1
9 1 96 5 1
10 1 98 8 1
11 2 37 5 0.33 6 0.67 Yes
12 1 96 7 1
13 1 80 7 1
14 1 37 5 1
15 2 59 4 0.57 6 0.43 No
16 1 low level 4 1
17 2 61 5 0.75 7 0.25 No
18 2 58 4 0.47 8 0.53 Yes
19 1 46 5 1
20 1 70 10 1
21 3 98 5 0.29 7 0.44 8 0.27 Yes
22 1 96 8 1
23 2 80 4 0.27 6 0.73 Yes
24 2 96 5 0.23 7 0.77 Yes
25 1 98 4 1
26 2 98 6 0.51 7 0.49 No
27 2 99 5 0.54 6 0.46 No
Patient16 POLG
1 1 14 4 1
2 1 84 6 1
3 1 91 7 1
4 1 u.m 7 1
5 3 82 4 0.39 5 0.23 8 0.38 No
6 1 95 5 1
7 2 62 6 0.73 7 0.27 No
8 1 94 6 1
9 2 67 6 0.37 7 0.63 Yes
10 1 92 7.5 1
11 2 57 6 0.17 8.5 0.83 Yes
12 1 43 6 1
13 2 38 6.5 0.43 7.5 0.57 Yes
14 1 89 6 1
15 1 u.m 2 1
16 2 23 5 0.53 7 0.47 No
17 1 46 9 1
18 1 72 7 1
19 1 34 7 1
20 2 67 3 0.54 7 0.46 No
21 1 82 6 1
22 1 31 4 1
23 2 76 6 0.57 8 0.43 No
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Table 3. Continued
Deletion 1 Deletion 2 Deletion 3
Fibre
No. of
deletions
ND4/ND1
% deletion
load Size (Kb) Proportion Size (Kb) Proportion Size (Kb) Proportion
Is the largest
deletion
highest level?
24 1 44 6 1
25 1 52 7 1
26 1 27 5 1
Key: u.m = unmeasurable
Figure 5. Mitochondrial DNA deletion spectra from patients 3, 6, 12 and 15. Long range PCR was used to amplify the mitochondrial DNA (mtDNA)
from single muscle fibres (n = 21), and then the amplicons sequenced to determine breakpoints. Size and position within the mitochondrial genome of
all mtDNA deletions identified by 12 Kb long-range PCR are presented as coloured curved lines. Lines endings on the left and right mark the 5′ and 3’
breakpoints, respectively.
(36.6%) completely removed OL. This is similar to previous
reports in IBM where sequencing demonstrated that 1 in 3
mtDNAdeletions extended into theminor arc removingOL
(19). The existence and clonal expansion of mtDNA lack-
ingOL is difficult to explain, given previous findings that the
origins of replication are essential for mtDNA replication
(21). However, it has previously been demonstrated that
PCR amplicons lacking OL are likely to have duplications
and contain both a wild-type genome as well as a deleted
genome (22). Such duplications have previously been ob-
served in IBM (19) and also in patients with MGME1 mu-
tations (23). Unfortunately, we were unable to check for
mtDNA duplications here and due to the inherent bias of
long-range PCR for smaller mtDNA species we would not
detect these. The presence of duplications could explain the
phenotype in cells, where COXI-III genes were deleted but
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CIV protein levels were preserved. Of these cells, five out of
nine have mtDNA deletions removing OL and breakpoints
that disrupt either anMT-ND gene or mt-tRNA. This sug-
gests there may be duplications with breakpoints that affect
CI, explaining their isolated CI deficiency, or alternatively
that there are additional deletions that we are not detecting.
Deletions arise in the mtDNA of post-mitotic cells in pa-
tients with mtDNAmaintenance disorders, but also during
ageing, IBM and Parkinson’s disease among other disease
conditions. mtDNA deletions are thought to form due to
errors during replication (24), repair (25) or a combination
of the two (26), with the rate of mtDNA deletion formation
likely dependent on the disease, the tissue andmechanism of
mtDNA replication. The sequences surrounding the break-
points can give us insight into how these deletions were
formed (25). The proportion of mtDNA deletions with re-
peat sequences and length of repeats we report here are sim-
ilar to those reported in IBM, where 39.4% were reported
to have repeats (19). In comparison in ageing muscle 80% of
mtDNA deletions were found to have repeats (7), which is
similar to findings in the substantia nigra in ageing, Parkin-
son’s disease and a patient with a POLG mutation (27).
Whilst evidence at present points towards mtDNA deletion
formation during replication (28,29), a clear mechanism for
how mtDNA deletions without repeats would form during
replication is missing and so their formation during repair
cannot be ruled out.
Data presented here from both long-range PCR and
smPCR in patients with mtDNA maintenance disorders
demonstrate thatmultiplemtDNAdeletions occur in∼35%
of muscle fibres, with up to 10% of all muscle fibres contain-
ing three mtDNA deletion species. This is similar to reports
in IBM (19) and demonstrates that up to three mtDNA
deletion species can clonally expand to detectable levels
within amuscle fibre. There is still uncertainty as regards the
exact mechanisms by which mtDNA deletions clonally ex-
pand in patients with mtDNA maintenance disorders. The
random genetic drift theory (30) proposes that mtDNAmu-
tations accumulate randomly through relaxed replication of
mtDNA. ‘Survival of the smallest’ theory (20) proposes that
the smaller size of mtDNA molecules containing deletions
allows for faster replication and therefore gives the deleted
species a replicative advantage. As such we investigated the
possibility of a replicative advantage using smPCR.
If a replicative advantage for smaller mtDNA molecules
were present, we would expect to see significant numbers
of muscle fibres where the smallest mtDNA molecules (the
largest deletions) had clonally expanded to be most preva-
lent. We observed the smallest species being most prevalent
in ∼40% of the cells with multiple deletions that we ob-
served across three patients. However, we cannot currently
assess whether the full set of observations from these cells,
as presented in Table 3, is significantly different from that we
might expect under the hypothesis of random genetic drift.
Assessment is complicated by the fact that a small replica-
tive advantagemight take a long time tomanifest and by the
fact that our patients (and indeed individual cells within pa-
tients) have experienced varying times since deletions arose.
Further work is therefore required to test whether these
novel, single cell data are compatible with models of clonal
expansion, including survival of the smallest, random ge-
netic drift (30) and the recently described perinuclear niche
hypothesis (31).
Here we perform in-depth, single-cell analysis to attempt
to correlate quantitative analysis of both mitochondrial ge-
netics and respiratory chain deficiency in mtDNA mainte-
nance disorders. Whilst we are able to correlate the over-
all mutation load with the degree of respiratory chain defi-
ciency, the multiple mtDNA deletions make more in depth
analysis of genes affected more complex. Long-range PCR
and sequencing analysis do, however, demonstrate that the
number of mtDNA deletions present and the percentage of
breakpoints associated with repeat sequences are consistent
with results from IBM. Finally, we present smPCR data
that could, with further analysis, be used to assess quan-
titative hypotheses about the clonal expansion of mtDNA
deletions.
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